The administration's pro-patent stance could completely restructure the innovation ecosystem, changing where money flows and ...

Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret ...

Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of its patent for an innovative enzymatic method to ...

The issuance of this patent marks another key milestone as FluidForm Bio continues to build a strong and defensible IP portfolio and extend its leadership in bioprinted regenerative medicine. The ...

Imagine a world where the very essence of life—genes, species, and the building blocks of nature—can be claimed, bought, and ...

YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and ...

Recently, Professor Frédéric Veyrier at the Institut national de la recherche scientifique (INRS) and his team developed a new genetic tool based on a family of specific enzymes called Ssn that allows ...

The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...

The future of food security is increasingly threatened by the aggressive patenting strategies of major biotech corporations, according to the experts in agriculture and legal research. Farmers are ...

In this video, we explain how the United States Patent and Trademark Office grants ... STAT takes you inside academic labs, biotech boardrooms, and political backrooms, casting a critical eye ...

Work at Vir Biotechnology Inc. has led to the identification of 3C-like proteinase (3CLpro; Mpro; nsp5) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of SARS-CoV-2 ...